Finance

Lists
6L8:FRA
Pulse Biosciences Inc
€42.80
0.00%
(0.00) 1D
Aug 24, 8:18:43 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6L8...
Mkt. cap
3.50B
Avg. vol.
39.00
Volume
0.00
52-wk high
€40.80
52-wk low
€10.80
No. of employees
116
Mkt. cap
3.50B
Avg. vol.
39.00
Volume
0.00
52-wk high
€40.80
52-wk low
€10.80
No. of employees
116
About Pulse Biosciences Inc
CEO-
Employees116
Founded2014
HeadquartersHayward, California, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
86.00K
264.00K
401.00K
434.00K
Cost of goods sold
279.00K
260.00K
370.00K
273.00K
Cost of revenue
279.00K
260.00K
370.00K
273.00K
Research and development expenses
11.39M
10.93M
12.59M
16.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.78M
7.33M
6.59M
8.46M
Operating expense
20.17M
18.26M
19.18M
25.43M
Total operating expenses
20.45M
18.52M
19.55M
25.71M
Operating income
-20.37M
-18.25M
-19.15M
-25.27M
Other non operating income
-19.00K
-5.00K
-24.00K
15.00K
EBT including unusual items
-19.38M
-17.43M
-18.58M
-24.66M
EBT excluding unusual items
-19.38M
-17.43M
-18.58M
-24.66M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.38M
-17.43M
-18.58M
-24.66M
Net profit margin
-22,540.70%
-6,603.41%
-4,633.67%
-5,681.34%
Earnings per share
-
-0.18
-0.24
-0.28
Interest and investment income
1.00M
825.00K
593.00K
600.00K
Interest expense
-
-
-
-
Net interest expenses
1.00M
825.00K
593.00K
600.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.11M
-17.99M
-18.90M
-25.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps